BR0306960A - Uso de composição polimérica no tratamento de doença gastrintestinal - Google Patents

Uso de composição polimérica no tratamento de doença gastrintestinal

Info

Publication number
BR0306960A
BR0306960A BR0306960-5A BR0306960A BR0306960A BR 0306960 A BR0306960 A BR 0306960A BR 0306960 A BR0306960 A BR 0306960A BR 0306960 A BR0306960 A BR 0306960A
Authority
BR
Brazil
Prior art keywords
treatment
gastrointestinal disease
polymeric composition
disease
propenal
Prior art date
Application number
BR0306960-5A
Other languages
English (en)
Inventor
Graham John Hamilton Melrose
Andrew James Huxham
Damon Matthew Goadby Tilbrook
Vincent Leonard Wycoco
Original Assignee
Chemeq Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/053,088 external-priority patent/US7629002B2/en
Priority claimed from AUPS3271A external-priority patent/AUPS327102A0/en
Application filed by Chemeq Ltd filed Critical Chemeq Ltd
Publication of BR0306960A publication Critical patent/BR0306960A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE COMPOSIçãO POLIMéRICA NO TRATAMENTO DE DOENçA GASTRINTESTINAL". Um método de tratamento de doença gastrintestinal por administração de antimicrobiano polimérico compreendendo um derivado de ácido poli(2-propenal-2-propenóico) formado por reação entre um ácido poli(2-propenal-2-propenóico) e um álcool ou fenol para formar grupos carbonila protegidos. A invenção também se relaciona à composição para uso no tratamento de doença gastrintestinal.
BR0306960-5A 2002-01-18 2003-01-17 Uso de composição polimérica no tratamento de doença gastrintestinal BR0306960A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/053,088 US7629002B2 (en) 2000-02-16 2002-01-18 Antimicrobial polymeric compositions and method of treatment using them
AUPS3271A AUPS327102A0 (en) 2002-06-28 2002-06-28 Method of treatment or prophylaxis of gastrointestinal diseases
PCT/AU2003/000039 WO2003061672A1 (en) 2002-01-18 2003-01-17 Method of treatment of gastrointestinal disease and polymeric composition for use therein

Publications (1)

Publication Number Publication Date
BR0306960A true BR0306960A (pt) 2004-11-23

Family

ID=27614010

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0306960-5A BR0306960A (pt) 2002-01-18 2003-01-17 Uso de composição polimérica no tratamento de doença gastrintestinal

Country Status (8)

Country Link
EP (1) EP1474155A4 (pt)
KR (1) KR100971520B1 (pt)
CN (1) CN1617733B (pt)
BR (1) BR0306960A (pt)
CA (1) CA2472685C (pt)
MX (1) MXPA04007005A (pt)
NZ (1) NZ533811A (pt)
WO (1) WO2003061672A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145566A (en) * 2000-02-16 2006-10-05 Chemeq Ltd Antimicrobial polymeric compositions
EP1800713A1 (de) 2005-12-22 2007-06-27 Basf Aktiengesellschaft Verwendung von Alkoxylaten ein- und mehrwertiger Alkohole oder eines Derivats davon als Antibiotikaersatz in der Tierenährung
ES2556732T3 (es) * 2007-11-07 2016-01-19 Recce Limited Polímeros anti-microbianos y sus composiciones
EP3220923B1 (en) 2014-11-18 2019-08-28 Recce Pharmaceuticals Ltd Copolymer and method for treatment of bacterial infection
CN108472311B (zh) * 2016-02-19 2021-06-22 瑞克制药有限公司 抗病毒剂和治疗病毒感染的方法
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23983A (en) * 1986-12-23 1990-02-09 Biopolymers Ltd Biostatic and biocidal composition
AUPN327695A0 (en) * 1995-05-30 1995-06-22 Chemeq Pty. Limited Chemotherapeutic compositions
JP3692301B2 (ja) * 1998-07-17 2005-09-07 ケメック・リミテッド 重合体化合物およびこれを処方する方法
IL145566A (en) * 2000-02-16 2006-10-05 Chemeq Ltd Antimicrobial polymeric compositions

Also Published As

Publication number Publication date
CN1617733B (zh) 2010-04-07
NZ533811A (en) 2005-07-29
EP1474155A4 (en) 2008-04-16
CA2472685A1 (en) 2003-07-31
CN1617733A (zh) 2005-05-18
KR20040081135A (ko) 2004-09-20
EP1474155A1 (en) 2004-11-10
WO2003061672A1 (en) 2003-07-31
KR100971520B1 (ko) 2010-07-21
CA2472685C (en) 2010-07-20
MXPA04007005A (es) 2005-06-17

Similar Documents

Publication Publication Date Title
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
ATE365703T1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen
DE60314495D1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
BR0115427A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto
CY1110259T1 (el) Ανοσορυθμιστης
BRPI0412893A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto
SE0102315D0 (sv) Compounds
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
ATE253063T1 (de) 5-ht1f-agonisten
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
BR0201862A (pt) Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
BRPI0517150A (pt) composição polimérica tendo propriedades de extrusão de fundido melhoradas
WO2005000985A3 (en) Antimicrobial phenol containing cyanoacrylate adhesive compositions
CY1108482T1 (el) Συστημα υποδοριας διανομης, μεθοδος παρασκευης του και χρηση του για την αγωγη διαταραχων xολινεργικης ανεπαρκειας
TR200800691T2 (tr) Miyelin kaybettiren hastalıkların ya da durumların tedavi yöntemi.
BRPI0415123A (pt) uso de l-butilftalida e respectiva composição farmacêutica
BR0306960A (pt) Uso de composição polimérica no tratamento de doença gastrintestinal
SE0003476D0 (sv) Compounds
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
ATE312626T1 (de) Mucoadhäsive, wärmeaktivierbare zubereitung als träger für medikamente

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.